Analysis shows increasing 5-year conditional survival rates for gynecologic malignancies with radiation therapy, indicating improvements in patient prognosis over time.
Key Points
The 5-year conditional survival rate improved progressively for gynecologic malignancies treated with radiation over five years.
Out of 59,441 patients, 40% underwent external beam radiation therapy, and 28% received combined therapies, indicating diverse treatment approaches.
Using the SEER database, the analysis tracked survival rates annually, showcasing the effectiveness of radiation treatments on long-term outcomes.
These insights into conditional survival may aid in survivorship care planning and inform evidence-based healthcare policies.